Long-term, low-dose antiviral treatment opens doors for treating shingles in the eye. Will antiviral drug valacyclovir ...

That's what happened to eye surgeon Dr. Elisabeth Cohen, who was forced to stop operating. She tested a new way to treat ...

Around 15,002 doses of the Shingrix vaccine against shingles have been administered to senior citizens and immunocompromised ...

For a long time, scientists assumed the virus that causes both chickenpox and shingles stayed dormant in the body after infection. But new evidence suggests the shingles virus may be linked to ...

The launch of the GSK ‘Understanding Shingles’ research findings aims to raise awareness and address the lack of knowledge ...

Shingles is a common condition that lies dormant in a third of adults over their lifetime. A pharmacist has shared the key ...

A pharmacist is urging the public to be on alert for shingles, a common "dormant" condition that affects one in three adults ...

For the millions of Americans who suffer from shingles each year, the threat of vision loss has long been a looming concern.

The researchers also think shingles could lead to “neuroinflammation, cerebral vasculopathy, direct neuronal damage, and the ...

It began with a burning pain in her right eye. At first, Elisabeth Cohen thought she’d gotten something in it. But the next ...

A bus with scientific pamphlets and educational programs for the elderly began touring 35 cities in nine provinces and ...

Long-term, low-dose antiviral treatment reduces the risk for potentially vision-damaging bouts of inflammation and infection, as well as pain, which occur when shingles affects the eye, according to ...